These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38184691)

  • 1. Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE.
    Gouriou C; Lemanski C; Pommier P; Le Malicot K; Saint A; Rivin Del Campo E; Evin C; Quero L; Regnault P; Baba-Hamed N; Ronchin P; Crehange G; Tougeron D; Menager-Tabourel E; Diaz O; Hummelsberger M; de la Rocherfordiere A; Drouet F; Vendrely V; Lièvre A
    Br J Cancer; 2024 Mar; 130(5):769-776. PubMed ID: 38184691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of
    Combet-Curt V; Buchalet C; Malicot KL; Lemanski C; Deshayes E; Bonichon-Lamichhane N; Lièvre A; Huguet F; Tlili G; Vendrely V
    J Nucl Med; 2024 Jun; ():. PubMed ID: 38936973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE.
    Vendrely V; Lemanski C; Pommier P; LE Malicot K; Saint A; Rivin Del Campo E; Regnault P; Baba-Hamed N; Ronchin P; Crehange G; Tougeron D; Menager-Tabourel E; Diaz O; Hummelsberger M; Minsat M; Drouet F; Larrouy A; Peiffert D; Lievre A; Zasadny X; Hautefeuille V; Mornex F; Lepage C; Quero L;
    Radiother Oncol; 2023 Jun; 183():109542. PubMed ID: 36813175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort.
    Bacci M; Quero L; Barbier E; Parrot L; Juguet F; Pommier P; Bazire L; Etienney I; Baba-Hamed N; Spindler L; François E; Ronchin P; Campo ERD; Lemanski C; Lièvre A; Siproudhis L; Abramowitz L; Lepage C; Vendrely V
    Dig Liver Dis; 2021 Jun; 53(6):776-784. PubMed ID: 33867291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Toxicity of (Chemo)Radiation Therapy in HIV+ Patients with Squamous Cell Anal Cancer, a Subgroup Analysis of the National Multicenter Cohort FFCD-ANABASE.
    Evin C; Quéro L; Le Malicot K; Blanchet-Deverly S; Evesque L; Buchalet C; Lemanski C; Hamed NB; Rivin Del Campo E; Bauwens L; Pommier P; Lièvre A; Gouriou C; Tougeron D; Macé V; Sergent G; Diaz O; Zucman D; Mornex F; Locher C; De la Rochefordière A; Vendrely V; Huguet F
    Int J Radiat Oncol Biol Phys; 2024 Jun; ():. PubMed ID: 38912999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trial.
    Vendrely V; Ronchin P; Minsat M; Le Malicot K; Lemanski C; Mirabel X; Etienne PL; Lièvre A; Darut-Jouve A; de la Fouchardière C; Giraud N; Breysacher G; Argo-Leignel D; Thimonnier E; Magné N; Abdelghani MB; Lepage C; Aparicio T;
    Radiother Oncol; 2023 Sep; 186():109742. PubMed ID: 37315583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
    Kim S; Jary M; André T; Vendrely V; Buecher B; François E; Bidard FC; Dumont S; Samalin E; Peiffert D; Pernot S; Baba-Hamed N; El Hajbi F; Bouché O; Desrame J; Parzy A; Zoubir M; Louvet C; Bachet JB; Nguyen T; Abdelghani MB; Smith D; De La Fouchardière C; Aparicio T; Bennouna J; Gornet JM; Jacquin M; Bonnetain F; Borg C
    BMC Cancer; 2017 Aug; 17(1):574. PubMed ID: 28841909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoradiotherapy versus radiotherapy alone in the management of early-stage anal squamous cell carcinoma: A comparative analysis of the French cohort FFCD-ANABASE.
    Buchalet C; Lemanski C; Pommier P; Le Malicot K; Bonichon-Lamichhane N; Evesque L; Diaz O; Ronchin P; Quero L; Campo ERD; Tougeron D; Salas S; Bengrine-Lefevre L; Lepage C; Vendrely V
    Dig Liver Dis; 2024 Jul; ():. PubMed ID: 39003165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Outcomes With Dose Escalation Using Modern Radiotherapy Techniques: A Retrospective Review of Anal Cancer Treated at a Large Academic Institution Between 2010 and 2016.
    Murchison SC; DeVries KJ; Atrchian S
    Cureus; 2020 Oct; 12(10):e10989. PubMed ID: 33209545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of tobacco smoking on the patient's outcome after (chemo)radiotherapy for anal cancer.
    Lerman J; Hennequin C; Etienney I; Abramowitz L; Goujon G; Gornet JM; Guillerm S; Aparicio T; Valverde A; Cattan P; Quéro L
    Eur J Cancer; 2020 Dec; 141():143-151. PubMed ID: 33137590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of anal cancer patients at the Ottawa hospital.
    Abunassar M; Reinders J; Jonker DJ; Asmis T
    Eur J Surg Oncol; 2015 May; 41(5):653-8. PubMed ID: 25776438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase II Study of Capecitabine/Oxaliplatin With Concurrent Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Anal Canal.
    Eng C; Jácome AA; Das P; Chang GJ; Rodriguez-Bigas M; Skibber JM; Wolff RA; Qiao W; Xing Y; Sethi S; Ohinata A; Crane CH
    Clin Colorectal Cancer; 2019 Dec; 18(4):301-306. PubMed ID: 31350201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patients.
    Vendrely V; Henriques de Figueiredo B; Rio E; Benech J; Belhomme S; Lisbona A; Frison E; Doussau A; Nomikossoff N; Mahé MA; Kantor G; Maire JP
    Radiat Oncol; 2015 Aug; 10():170. PubMed ID: 26268888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of local therapy in the management of patients with metastatic anal squamous cell carcinoma: a National Cancer Database study.
    Atallah RP; Zhang Y; Zakka K; Jiang R; Huang Z; Shaib WL; Diab M; Akce M; Wu C; El-Rayes BF; Alese OB
    J Gastrointest Oncol; 2022 Oct; 13(5):2306-2321. PubMed ID: 36388688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of radical radiotherapy combined with different regimens of chemotherapy on radiation intestinal injury in patients with non-metastatic anal squamous cell carcinoma].
    Pang XL; Liu S; Liu YP; Chen HY; He F; Zheng J; Wan XB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):977-983. PubMed ID: 34823298
    [No Abstract]   [Full Text] [Related]  

  • 16. Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma.
    Kim S; Meurisse A; Spehner L; Stouvenot M; François E; Buecher B; André T; Samalin E; Jary M; Nguyen T; El Hajbi F; Baba-Hamed N; Pernot S; Kaminsky MC; Bouché O; Desrame J; Zoubir M; Ghiringhelli F; Parzy A; de la Fouchardiere C; Boulbair F; Lakkis Z; Klajer E; Jacquin M; Taieb J; Vendrely V; Vernerey D; Borg C
    Ther Adv Med Oncol; 2020; 12():1758835920975356. PubMed ID: 33329760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma.
    Untiedt S; Rolf D; Scobioala S; Wolters H; Elsayad K; Oertel M; Kittel C; Pascher A; Rijcken E; Ullerich H; Glasbrenner B; Eich HT
    Strahlenther Onkol; 2023 Aug; 199(8):749-760. PubMed ID: 36862155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience.
    Kim KH; Chang JS; Keum KC; Ahn JB; Lee CG; Koom WS
    Radiat Oncol J; 2013 Mar; 31(1):25-33. PubMed ID: 23620866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.
    Kim S; Buecher B; André T; Jary M; Bidard FC; Ghiringhelli F; François É; Taieb J; Smith D; de la Fouchardière C; Desramé J; Samalin E; Parzy A; Baba-Hamed N; Bouché O; Tougeron D; Dahan L; El Hajbi F; Jacquin M; Rebucci-Peixoto M; Spehner L; Vendrely V; Vernerey D; Borg C
    BMC Cancer; 2020 Apr; 20(1):352. PubMed ID: 32334548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.